you are into something don't you. Are you the one taking the Lead for the Vegas party? Very interesting behavior from you. You might be still wanting the $10 gap to be filled. Lot of rats here, imo.
Good find KevGee, and not even a mention of EPA, does bode well for V (EPA) differentiation - BUT to come out now and not even mention it, how on earth can that come out now and omit V and be considered a serious EMA review. What a disappointment no V acknowledgement...
It's not even an official decision yet, still needs to be approved by the EU:
The review of omega-3 fatty acid medicines was started on 22 March 2018 at the request of the Swedish medicines agency under Article 31 of Directive 2001/83/EC.
The review has been carried out by the Committee for Medicinal Products for Human Use (CHMP), responsible for questions concerning medicines for human use, which has adopted the Agency’s opinion. The CHMP opinion will now be forwarded to the European Commission, which will issue a final legally binding decision applicable in all EU Member States.